Get started
ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUSROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUSROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS

ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

0TDF chart


Full chart

0TDF upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪261.11 B‬ USD
Dividend yield (indicated)
2.09%
Price to earnings Ratio (TTM)
23.6
Basic EPS (TTM)
1.8 USD
Net income (FY)
‪9.40 B‬ USD
Revenue (FY)
‪68.69 B‬ USD
Shares float
‪5.52 B‬
Beta (1Y)
0.49

About ROCHE I


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
FIGI
BBG00JRY9DR7
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as 0TDF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0TDF news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

0TDF highest yielding bonds


A3K88A
ROCHE KAPITALMARKT AG 2022-23.09.32 GUARANTEED
Yield to maturity
—
Maturity date
Sep 23, 2032
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
—
Maturity date
Nov 28, 2044
CHGCY5766482
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
—
Maturity date
Mar 8, 2031
A3K2NX
ROCHE KAPITALMARKT AG 2022-25.02.37 GUARANTEED REG S
Yield to maturity
—
Maturity date
Feb 25, 2037
A3K88B
ROCHE KAPITALMARKT AG 2022-23.06.26 GUARANTEED
Yield to maturity
—
Maturity date
Jun 23, 2026
CHGCY5885609
Roche Holdings, Inc. 4.203% 09-SEP-2029
Yield to maturity
—
Maturity date
Sep 9, 2029
CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
—
Maturity date
Dec 13, 2051
CHGCY5885611
Roche Holdings, Inc. 4.592% 09-SEP-2034
Yield to maturity
—
Maturity date
Sep 9, 2034
CHGCY5317198
Roche Holdings, Inc. 2.076% 13-DEC-2031
Yield to maturity
—
Maturity date
Dec 13, 2031
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
—
Maturity date
Mar 8, 2034
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
—
Maturity date
Mar 8, 2034

See all 0TDF bonds 

Sparks


Curated watchlists where 0TDF is featured.

See all sparks